+8.1%
WDAY vs MRNA
+806.0%
-798.0%
-63.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | +1.3% | -3.6% | -2.4% |
| 7D | -9.1% | -13.8% | +4.8% | -8.4% |
| 30D | -15.0% | -17.7% | +2.6% | -14.4% |
| 3M | -12.6% | +14.3% | -26.9% | -13.9% |
| 6M | +34.0% | +336.0% | -301.9% | +16.9% |
| YTD | -19.3% | +575.9% | -595.2% | -32.9% |
| 1Y | -22.6% | +724.4% | -746.9% | -36.8% |
| 3Y | -25.2% | +160.8% | -185.9% | -35.0% |
| 5Y | -39.5% | -24.4% | -15.1% | -44.3% |
| All | +8.1% | +806.0% | -798.0% | -14.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling